Contemporary view of the clinical relevance of magnesium homeostasis

Annals of Clinical Biochemistry

Volumn 51, Issue 2, 2014, Pages 179-188

  Ayuk, John ^a   Gittoes, Neil J L ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

electrolyte metabolism; hypermagnesaemia; hypomagnesaemia; Magnesium; proton pump inhibitor

Indexed keywords

ELECTROLYTE METABOLISM; HYPERMAGNESAEMIA; HYPOMAGNESAEMIA; MAGNESIUM; PROTON-PUMP INHIBITOR;

HOMEOSTASIS; HUMANS; MAGNESIUM; METABOLIC DISEASES;

EID: 84898680907     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563213517628     Document Type: Review

References (53)

1. Whang R,Hampton EM,Whang DD.Magnesium homeostasis and clinical disorders of magnesium deficiency.Ann Pharmacother. 1994;28:220-226.
2. Saris NE,Mervaala E,Karppanen H, et al.Magnesium. An update on physiological, clinical and analytical aspects.Clin Chim Acta. 2000;294:1-26.
3. Konrad M,Schlingmann KP,Gudermann T.Insights into the molecular nature of magnesium homeostasis.Am J Physiol Renal Physiol. 2004;286:F599-F605.
4. Assadi F.Hypomagnesemia: an evidence-based approach to clinical cases.Iran J Kidney Dis. 2010;4:13-19.
5. Pathology Harmony Group. Clinical biochemistry outcomes, www acb org uk/docs/Pathology Harmony for web pdf (2011, accessed 4 December 2013).
6. Swaminathan R.Magnesium metabolism and its disorders.Clin Biochem Rev. 2003;24:47-66.
7. Ryan MF.The role of magnesium in clinical biochemistry: an overview.Ann Clin Biochem. 1991;28 (Pt 1): 19-26.
8. Romani AM.Cellular magnesium homeostasis.Arch Biochem Biophys. 2011;512:1-23.
9. Topf JM,Murray PT.Hypomagnesemia and hypermagnesemia.Rev Endocr Metab Disord. 2003;4:195-206.
10. Marier JR.Magnesium content of the food supply in the modern-day world.Magnesium. 1986;5:1-8.
11. Fine KD,Santa Ana CA,Porter JL, et al.Intestinal absorption of magnesium from food and supplements.J Clin Invest. 1991;88:396-402.
12. Amasheh S,Fromm M,Gunzel D.Claudins of intestine and nephron - a correlation of molecular tight junction structure and barrier function.Acta Physiol (Oxf). 2011;201:133-140.
13. Hou J,Goodenough DA.Claudin-16 and claudin-19 function in the thick ascending limb.Curr Opin Nephrol Hypertens. 2010;19:483-488.
14. Musso CG.Magnesium metabolism in health and disease.Int Urol Nephrol. 2009;41:357-362.
15. Nadler MJ,Hermosura MC,Inabe K, et al.LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability.Nature. 2001;411:590-595.
16. Schlingmann KP,Weber S,Peters M, et al.Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family.Nat Genet. 2002;31:166-170.
17. van der Wijst J,Hoenderop JG,Bindels RJ.Epithelial Mg2+ channel TRPM6: insight into the molecular regulation.Magnes Res. 2009;22:127-132.
18. de Baaij JHF,Hoenderop JJ,Bindels RJ.Regulation of magnesium balance: lessons learned from human genetic disease.Clin Kidney J. 2012;5:i15-i24.
19. Wagner CA.Disorders of renal magnesium handling explain renal magnesium transport.J Nephrol. 2007;20:507-510.
20. Cao G,van der Wijst J,van der Kemp A, et al.Regulation of the epithelial Mg2+ channel TRPM6 by estrogen and the associated repressor protein of estrogen receptor activity (REA).J Biol Chem. 2009;284:14788-14795.
21. Mouw DR,Latessa RA,Hickner J.Clinical inquiries. What are the causes of hypomagnesemia?.J Fam Pract. 2005;54:174-176.
22. Agus ZS.Hypomagnesemia.J Am Soc Nephrol. 1999;10:1616-1622.
23. Nuytten D,Van HJ,Meulemans A, et al.Magnesium deficiency as a cause of acute intractable seizures.J Neurol. 1991;238:262-264.
24. Shils ME.Experimental human magnesium depletion.Medicine (Baltimore). 1969;48:61-85.
25. Atsmon J,Dolev E.Drug-induced hypomagnesaemia: scope and management.Drug Saf. 2005;28:763-788.
26. White RE,Hartzell HC.Magnesium ions in cardiac function. Regulator of ion channels and second messengers.Biochem Pharmacol. 1989;38:859-867.
27. Whang R,Ryder KW.Frequency of hypomagnesemia and hypermagnesemia. Requested vs routine.JAMA. 1990;263:3063-3064.
28. Huang CL,Kuo E.Mechanism of hypokalemia in magnesium deficiency.J Am Soc Nephrol. 2007;18:2649-2652.
29. Rude RK,Oldham SB,Singer FR.Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency.Clin Endocrinol (Oxf). 1976;5:209-224.
30. Sharratt CL,Gilbert CJ,Cornes MC, et al.EDTA sample contamination is common and often undetected, putting patients at unnecessary risk of harm.Int J Clin Pract. 2009;63:1259-1262.
31. Saha H,Harmoinen A,Karvonen AL, et al.Serum ionized versus total magnesium in patients with intestinal or liver disease.Clin Chem Lab Med. 1998;36:715-718.
32. Brasier AR,Nussbaum SR.Hungry bone syndrome: clinical and biochemical predictors of its occurrence after parathyroid surgery.Am J Med. 1988;84:654-660.
33. Chernow B,Bamberger S,Stoiko M, et al.Hypomagnesemia in patients in postoperative intensive care.Chest. 1989;95:391-397.
34. Frisch LS,Mimouni F.Hypomagnesemia following correction of metabolic acidosis: a case of hungry bones.J Am Coll Nutr. 1993;12:710-713.
35. Prebble JJ.Primary infantile hypomagnesaemia: report of two cases.J Paediatr Child Health. 1995;31:54-56.
36. Ross JR,Dargan PI,Jones AL, et al.A case of hypomagnesaemia due to malabsorption, unresponsive to oral administration of magnesium glycerophosphate, but responsive to oral magnesium oxide supplementation.Gut. 2001;48:857-858.
37. Epstein M,McGrath S,Law F.Proton-pump inhibitors and hypomagnesemic hypoparathyroidism.N Engl J Med. 2006;355:1834-1836.
38. Cundy T,Dissanayake A.Severe hypomagnesaemia in long-term users of proton-pump inhibitors.Clin Endocrinol (Oxf). 2008;69:338-341.
39. Kuipers MT,Thang HD,Arntzenius AB.Hypomagnesaemia due to use of proton pump inhibitors - a review.Neth J Med. 2009;67:169-172.
40. Mackay JD,Bladon PT.Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series.QJM. 2010;103:387-395.
41. Swaminathan K,Wilson J.Elusive cause of hypomagnesaemia.BMJ. 2011;343:d5087-d5087.
42. Serfaty-Lacrosniere C,Wood RJ,Voytko D, et al.Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans.J Am Coll Nutr. 1995;14:364-368.
43. Quamme GA.Recent developments in intestinal magnesium absorption.Curr Opin Gastroenterol. 2008;24:230-235.
44. Kennedy A,Gittoes N,Ayuk J.Parathyroid hormone concentrations in proton pump inhibitor induced hypomagnesaemia.Endocr Abstr. 2011;25:P15-P15.
45. Huey CG,Chan KM,Wong ET, et al.Los Angeles County-University of Southern California Medical Center clinical pathology case conference: extreme hypermagnesemia in a neonate.Clin Chem. 1995;41:615-618.
46. Schelling JR.Fatal hypermagnesemia.Clin Nephrol. 2000;53:61-65.
47. Cholst IN,Steinberg SF,Tropper PJ, et al.The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects.N Engl J Med. 1984;310:1221-1225.
48. Cruikshank DP,Pitkin RM,Reynolds WA, et al.Effects of magnesium sulfate treatment on perinatal calcium metabolism. I. Maternal and fetal responses.Am J Obstet Gynecol. 1979;134:243-249.
49. Spital A,Greenwell R.Severe hyperkalemia during magnesium sulfate therapy in two pregnant drug abusers.South Med J. 1991;84:919-921.
50. Sipes SL,Weiner CP,Gellhaus TM, et al.The plasma renin-angiotensin system in preeclampsia: effects of magnesium sulfate.Obstet Gynecol. 1989;73:934-937.
51. Bohman VR,Cotton DB.Supralethal magnesemia with patient survival.Obstet Gynecol. 1990;76:984-986.
52. Porath A,Mosseri M,Harman I, et al.Dead Sea water poisoning.Ann Emerg Med. 1989;18:187-191.
53. Ayuk J,Gittoes NJ.How should hypomagnesaemia be investigated and treated?.Clin Endocrinol (Oxf). 2011;75:743-746.